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Abstract
In this work there are presented different methods o f clinical analysis o f patients with intermittent claudication. The methods contain 
haemodynamic measurements, an assessment o f physiological parameters, an assessment o f the physical abilities o f a patient and ques­
tionnaires’ assessment. These methods are used for diagnosis o f intermittent claudication, the evaluation of patients’ condition after 
therapy as well as for describing patients’ functional performance and their quality o f living. Because o f the heterogenic character o f 
patients with intermittent claudication and their serious limitations in personal, vocational and social life, the parameters used for pa­
tient’s characterization have to be reliable, complex, describing not only the progress o f the disease but also its influence on everyday 
life and quality o f life. Isolated haemodynamic measurements are not a proper method of a patient’s evaluation, their values do not 
correlate with the functional performance o f patients. Similarly, the improvement o f physical abilities that is seen during trainings, is 
not always visible in the values o f the haemodynamic parameters. These reasons indicate that a complex clinical analysis o f different 
parameters in patients with intermittent claudication is strongly advisable. The aim o f this study was to assess the effectiveness o f the 
most common methods that are used in the diagnosis o f patients suffering from intermittent claudication, with the indication of those 
that may be the most important for clinical and scientific research.
Słowa kluczowe
chromanie przestankowe, testy funkcjonalne, jakość życia 
Streszczenie
W pracy przedstawiono wybrane metody oceny klinicznej pacjentów z chromaniem przestankowym. Metody te obejmują podstawowe 
pomiary hemodynamiczne, ocenę możliwości fizycznych pacjenta oraz badania kwestionariuszowe. Stosowane badania służą zarówno 
diagnostyce chromania, jak również ocenie skuteczności stosowanej terapii, a także charakteryzują stan funkcjonalny i jakość życia 
chorych. Heterogenny charakter opisywanej grupy pacjentów oraz związane z chorobą znaczne ograniczenie aktywnego uczestnictwa 
chorego w życiu społecznym i zawodowym wymaga użycia miar rzetelnych, całościowo opisujących stopień zaawansowania choroby, 
jak  również jej wpływ na codzienne funkcjonowanie i jakość życia pacjentów. Na ogół odosobnione pomiary hemodynamiczne nie są 
właściwą metodą oceny a ich wartości nie korelują z możliwościami funkcjonalnymi pacjentów z chromaniem przestankowym. Po­
dobnie, poprawa możliwości wysiłkowych, obserwowana podczas treningu, nie zawsze odzwierciedla się w  poprawie wartości para­
metrów hemodynamicznych. Stąd też, w  diagnostyce chorych z chromaniem przestankowym zaleca się stosowanie złożonych metod 
oceny. Celem pracy była zarówno ocena skuteczności metod najczęściej stosowanych w diagnostyce chorych z chromaniem przestan­
kowym, jak i próba wskazania najbardziej przydatnych, zarówno dla celów klinicznych jak i badań naukowych.
INTRODUCTION
Intermittent claudication (Latin clau­
dicatio intermittens) is characterised 
by pain in the muscles of the lower 
limbs occurring during walking. This
pain forces the sufferer to terminate 
the exertion and to stop movement. 
This is the result of an insufficient 
oxygen supply under conditions of 
exertion resulting from a narrowing or 
occlusion of the artery in the course of
peripheral arterial disease (PAD) of the 
lower limbs.1 Restricted exercise abi­
lity accompanies a decrease in patient 
activity both in the house, work, as 
equally during free time, which results 
in a noticeable reduction in quality of
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Table 1
Classification o f peripheral arterial d isease o f the low er lim bs (PAD)
Rutherford Fontaine
Degree Category Clinical symptoms Degree Clinical symptoms
0 0 lack o f sub jective sym ptom s 0.90- 0.7 I lack o f sub jective sym ptom s
I 1 m ild c laud ication
■ m ild PAD
IIA mild claud ication
I 2 m oderate claud ication 0 .69-0 .41 IIB m oderate c laud ica tion  to
I 3 severe c laud ication m oderate PAD severe
II 4 rest pain < 0.4
severe PAD 
(critica l ischaem ia)
III rest pain
III 5 sm all degree o f tissue  dam age < 0.20 IV ulceration, necros is
III 6 large degree o f tissue  dam age
On the basis of the reports of the Trans Atlantic Inter-Society Consensus (TASC II) ,11 American Diabetes Association (ADA)76 and W. R. Hiatt77 
ABI -  ankle-brachial index
life23. However, this is not the funda­
mental problem in this group of pa­
tients, for the relatively mild problem 
that is intermittent claudication is 
most often a symptom of a generally 
occurring atherosclerosis process, the 
consequence of which is a high mor­
tality rate chiefly as a result of heart 
attacks and strokes occurring after 5, 
10 and 15 years from diagnosis being 
respectively 30%, 50% and 70%4. For 
this reason the question of an accurate 
and quick diagnosis, as equally the 
evaluation of the progress being made 
by treatment and the appropriate later 
monitoring of patients with intermit­
tent claudication, is an important 
clinical matter. Yet this most com­
mon symptom of PAD of the lower 
limbs is usually disregarded by pa­
tients and the symptoms treated as 
being muscular-skeletal in nature or 
connected with the process of the 
aging of the organism5. Equally doc­
tors' awareness of this problem is 
surprisingly low. Hirsch et al.6 show 
that only 49% of surveyed doctors 
knew that their patients had pre­
viously had diagnosed PAD of the 
lower limbs in relation to 83% of pa­
tients being conscious of their illness. 
As the PAD progresses so rest pains 
occur, localised in the foot, most 
often at night and when the legs are 
raised. At later stages of advance­
ment in PAD of the lower limbs 
there result ischemic changes: ulcera­
tions and necrosis7. We have em­
ployed Fontaine's classification or 
more exactly Rutherford’s (Table 1) 
in the evaluation of the degree of
disease advancement. The evaluation 
of the functional possibilities of the 
patient and the degree of disease ad­
vancement, as equally the evaluation 
of progress in treatment requires both 
practical methods as those objectively 
describing the patient’s state. The pro­
cedures employed should be precise, 
enabling reproducible results8, and 
should also incorporate a wide range 
of complaints connected with inter­
mittent claudication as a result of the 
heterogenic character of the patient 
group2. Besides which it is expected 
that the methods applied were well 
tolerated by patients, accessible and 
simple in application as well as being 
relatively inexpensive9.
The work presents methods for the 
clinical evaluation of patients with in­
termittent claudication with particular 
attention being devoted to functional 
diagnostics. Equally are discussed the 
basic non-invasive hemodynamic 
measurements that are possible for 
a physiotherapist to conduct and 
which constitute the basic diagnostic 
instruments as well as being an inte­
gral component of the exercise tests 
applied in patients with intermittent 
claudication.
HEMODYNAMIC MEASUREMENTS
The Ankle-Brachial Index (ABI) is
the basic non-invasive hemodynamic 
test used on patients with intermittent 
claudication ABI is calculated by di­
viding the results of blood pressure 
measurements at the level of the an­
kles in the lower limbs by the blood
pressure at the brachial artery, on the 
side where the blood pressure is 
higher. The correct value of the indi­
cator should be greater than 1, al­
though 0.9 is accepted as the point dif­
ferentiating correct values from the 
incorrect11011. The ABI demarcation 
is considered the best method for the 
identification of peripheral arteries 
disease of the lower extremities12. 
A regularity has been observed that 
patients with an ABI index of < 0.8 
experience intermittent claudication 
while with an ABI of < 0.3 they ex­
perience pain in the lower limb at rest 
(Table 1)12 High values of ABI (over 
1.4) are considered to be unreliable. 
Most often such a result is connected 
with rigid, calcified arteries, which 
may occur in patients with diabetes 
and renal failure11,12. ABI in accor­
dance with the recommendations of 
TASC II (TransAtlantic Inter-Society 
Consensus)11 should be routinely de­
noted in all patients aged 50-69 with 
symptoms of exertion pain of the lo­
wer limbs with factors of cardio-vas- 
cular disease development (diabetes, 
a case history of smoking) as well as 
patients over the age of seventy re­
gardless of whether risk factors ap­
pear. Unfortunately the ABI is rela­
tively poorly correlated with an in­
crease in the walking distance ob­
tained during the course of physical 
training, more than likely as a result of 
the complexity of the mechanisms 
leading to its improvement. Therefore 
it follows to remember that its low 
value cannot be the main criteria in 
the qualifying of a patient for vascular
2
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Figure 1
Changes in systolic pressure at ankle level in the minutes subsequent to exertion 
The shaded area represents the magnitude of the ischemic window
procedures. On the other hand in pa­
tients with intermittent claudication, in 
whom there appears isolated stenosis 
of the iliac artery, there may not occur 
a reduction in the arterial blood pres­
sure at rest and the ABI may be cor­
rect11. The ABI measurement provides 
important information in conditions of 
physical exertion, which means that 
even small changes in the arteries be­
come hemodynamically significant. 
Therefore it is recommended to com­
bine ABI tests with a walking test13. 
A fall in the ABI value by 15-20% 
following exercise indicates peripheral 
circulatory failure1112. Hemodynamic 
measurements are conducted therefore 
in patients at a state of rest as well as 
following physical exercise, for exam­
ple after a treadmill walking exercise. 
The lowest values of ABI indicators 
as well as systolic pressure occur in 
the first minute following exercise and 
may continue for even 8-10 minutes14. 
Ischemia may be also simulated by the 
closing of arterial flow by means of 
a blood pressure cuff applied to the 
upper part of the leg and pumped up 
to above the systolic pressure. The 
occurring ischemic deficit is described 
as a so-called ischemic window15 and 
is presented graphically as a field; the 
magnitude of which is the function of 
the post-exercise fall in blood pressure 
at the level of the ankles (of the ABI 
indicator) in the ischemic limbs and
the time of the return of the parame­
ters to the initial value following the 
completion of exercise (Figure 1). The 
ischemic window well illustrates the 
ischemic deficiencies occurring in 
physical exertion as well as supplying 
reproducible objective data on the 
subject of improvement in the func­
tional state of patients undergoing 
treatment131516.
Segmentary measurements of sys­
tolic pressure are carried out with the 
aid of a Doppler head and specially 
designated blood pressure cuffs placed 
along the entire length of the limb (the 
upper part of the leg, above the knee, 
the shank, above the ankle). The mag­
nitude of blood pressure fall defines 
the degree of intensification in the 
changes within the circulatory system 
as well as helping to establish the lo­
cations of stenosis in the large arter- 
ies.1,10.
The indicator of systolic pressure 
in the hallux, is helpful in the evalua­
tion of healing potential. It is more often 
used with individuals with diabetes or 
with critical ischemia of the limbs than 
in patients with claudication.
From amongst the remaining non­
invasive diagnostic methods used in 
patients PAD of the lower limbs it 
follows to mention ultrasonography 
testing, magnetic resonance angio­
graphy (MRA), computer tomogra­
phy angiography (CTA) and also the
measurement of flow waves by means 
of the Doppler method and the regis­
tration of arterial volume17. However, 
none of the above methods correlate 
well with the functional state or 
equally with the amount of limitation 
experienced in daily life by patients 
with intermittent claudication. Be­
sides, the improvement in exercise 
possibilities observed in patients can 
equally not be correlated with the 
beneficial changes in the area of 
hemodynamic parameters. Therefore 
equally isolated hemodynamic meas­
urements are not an appropriate 
method of evaluation in this group of 
patients218. Also significant is the test­
ing of the functional possibilities of 
a patient and the limitation to quality 
of life. A patient with intermittent 
claudication despite a low ABI may 
have well developed peripheral circu­
lation, which in conditions of exertion of 
a low intensity will be able to 
satisfy the oxygen metabolism of the 
muscles of the lower limbs. Only an in­
crease in the intensity of exercise results 
in a disturbance in this balance and the 
occurrence of muscular pain. Therefore 
an accurate estimation of physical possi­
bilities has equally a significant mean­
ing, particularly in the aspect of an 
evaluation of progress in treatment.
EVALUATION OF PHYSICAL 
PERFORMANCE
Most often evaluation of a patient's 
physical performance is conducted by 
means of walking tests. Tests con­
ducted on treadmill are also applied, 
as well as without a treadmill on a flat 
surface (corridor). A cycloergometer 
is also used in evaluating the physical 
possibilities of patients with intermit­
tent claudication, as well as the appli­
cation of other methods for objective 
and subjective functional diagnostics.
Ergometric tests
Walking test on a treadmill with 
a constant load. The load is a con­
stant speed (most often 3.2 km/h) and 
the incline angle (in various works 
from 0-12%). The distance to the ap­
pearance of pain (ICD -  initial claudi­
cation distance) and the maximum 
intensity of pain, when the walk is ter­
minated are evaluated (ACD -  abso-
3
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lute claudication distance). The recur­
rence of the results expressed as an 
ICC value (ICC intraclass correlation 
coefficient) in a test at a speed of 2.4 
km/h and 7.5% incline of the treadmill 
are determined by Gardner et al.14 as 
0.53 for ICD and 0.55 for ACD. The 
variability of the test with constant 
load, valued with the CV (coefficient 
o f variance), is most often estimated 
as 30% for ACD and 40% for 
ICD19,20. Such a sizeable variance of­
ten requires the test to be repeated 
several times for individual patients. 
Degischer et al.21, in comparing vari­
ous protocols with constant load 
(speed: 2 km/h, 3.2 km/h, 4.0 km/h as 
well as a treadmill incline of 0% or 
12%), point to the increasing recur­
rence of measurements in the division 
0.61-0.95 for ACD in conjunction 
with an increasing load. The highest 
ICC=0.952 was obtained for ACD at 
a speed of 4 km/h and 12% of tread­
mill gradient, equally this test showed 
the lowest variability in the measure­
ment of ACD where the CV barely 
reached 9.7%. In control tests, during 
the evaluation of functional possibili­
ties following the completion of the 
programme, it was observed that pa­
tients from the control group dis­
played also an unexpected improve­
ment in the maximum walking dis­
tance at a range of 36% for ICD and 
25% for ACD18,22. Such an increase in 
the walking distance, not being a re­
sult of training, makes the possibility 
to evaluate the effects of therapy more 
difficult. Possibly the cause if the ob­
served improvement was a change in 
the biomechanics of gait during the 
repeated conduction of the test (the so- 
called learning effect). These changes, 
independent of treatment, should be 
taken into consideration when under­
taking a statistical analysis of each test 
based on a walking test with constant 
load2,18. Additionally, in order to ob­
tain statistically reliable results it is 
considered that the size of the experi­
mental group and the control group 
should not be less than 98 patients in 
those tests employing the test with 
constant load. It is estimated that this 
adaptive period should not be shorter 
than 6 minutes23.
The load and gradient of the tread­
mill are usually individually selected 
for each patient at the beginning of the
test, so as for it to be sufficient to end 
the attempt as a result of the maxi­
mum intensification of pain in the 
lower limbs. As a result of the diver­
sity in the walking possibilities of pa­
tients it is difficult to select invariable 
optimal parameters for their testing. If 
the degree of treadmill incline is too 
great, many patients experience pain 
very early on and are unable to pro­
duce a reliable test result. On the other 
hand, too low a treadmill incline angle 
in fitter patients may not cause pain 
induced problems and the test is stopped 
for reasons other than the pain of claudi­
cation2,18. Such a situation may also 
occur when improvement in the walking 
distance following treatment is evalu­
ated, for example through physical train­
ing. The initial intensity of effort on the 
treadmill, which was sufficient for the 
ACD measurement, may occur to be 
too small after therapy to stop the 
walk as a result of the maximum in­
tensification of muscular pain of the 
lower limbs. This problem may be re­
solved by selecting the initial load (the 
treadmill incline gradient) so that ACD 
is obtained in a relatively short time e.g. 
around 5 minutes. However, the risk of 
there being an absence of a precise des­
ignation of the magnitude of walking 
distance improvement in such a patient 
group, although not reducing the clinical 
value of the method itself, results in it 
becoming of little value for scientific 
purposes.
Despite the above limitations, tes­
ting with constant load is a frequently 
research instrument, one well tolerated 
by patients. It is a more natural form 
of physical activity in comparison 
with a test with increasing resistance 
and enables an easier expression of 
the improvement obtained, for exam­
ple, in the course of physical training 
in the form of an increase in the time 
or distance of the walk. A treadmill is 
a piece of generally available equip­
ment, while the conducting of the test 
itself requires the minimum of prepa­
ration. Testing has been for the last 40 
years, despite its inaccuracies, the 
main form of clinical evaluation of 
patients with intermittent claudica- 
tion2,18. However, in applying a test 
with a constant load it follows to re­
member not only about the necessity 
for an earlier, practical acquaintance 
on the part of the patient with this
form of movement, but also - as a re­
sult of the large variability in the re­
sults obtained - it is recommended that 
it is conducted several times. Usually 
the best result is taken for analysis. In 
applying a test with constant load for 
scientific purposes it is additionally 
necessary to ensure a respectively nu­
merical patient group.
Walking test on a treadmill with 
increasing load. Initially developed 
by Bruce et al. in the 1960s24, it served 
in the evaluation of cardiological pa­
tients. The research protocols were 
personally expanded and adapted for 
the evaluation of patients with claudi­
cation by Gardner and Hiatt18. In both 
protocols the walking speed is con­
stant and represents 2 mph (3.2 km/h) 
while the treadmill incline angle is 
increased by 3.5% every three minutes 
or by 2% every 2 minutes. As a result 
of equipment limitation (in the majo­
rity of treadmill the angle changes 
every 1%) more practical in applica­
tion is Gardner’s protocol. Both ICD 
and ACD are evaluated. Both in the 
test with a constant load as equally an 
increasing one, the pain complaints con­
nected with claudication are assessed by 
using a five-degree scale of pain intensi­
fication. Widely in use is the scale of the 
American College of Sport Medicine 
(ACSM)25 as well as that proposed by 
Regensteiner et al.26 (Table 2).
This means of testing is characterised 
by a noticeably greater accuracy in 
comparison with tests with a constant 
load. It is estimated that the CV is lo­
cated within the division 15%-25% for 
ICD as well as 12%-13% for ACD14. 
While Gardner et al.14 point to the high 
reproducibility of results in their proto­
col, reaching 0.89 for ICD and 0.93 for 
ACD. It is emphasised that a gradual 
treadmill test is useful for patients with 
various symptoms of claudication, in­
corporating patients over the age of 
702,27 as well as those with a low ABI 
index value5,27. Nevertheless Riebe et 
al.28 propose the use within a patient 
group with low physical fitness of 
a gradual test starting with a low speed 
beginning at 1.6 km/h and an incline of 
5%. Subsequently, every 5 minutes, the 
speed of the walk in increased by 0.8 
km/h with a constant 10% angle of in­
cline. After 20 minutes of walking the 
incline angle increases to 15% while 
the achieved speed of 4 km/h is main-
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Table 2
Frequently used scales for assessing patient's level o f claudication
Severity of claudication pain
G ardner
(ACSM)
0 1 2 3 4
no pain onset o f pain m oderate pain (from  w hich intense pain (from  m axim al pain 
it is possib le to d ivert the w hich it is im possib le  to (in to lerable pain) 
pa tien t's  a ttention ) d ivert the pa tien t's  a t­
tention)
R egenste iner 0 1 2 3 4
no pain onset claud ication m ild pain m oderate pain severe pain
Pain scale according to AW Gardner et al.14 on the basis of the American Collage of Sport Medicine (ACSM)25 and J.G. Regensteiner et al.26
tained. The authors, in emphasising the 
advantages of the test, point out the 
good correlation with the protocol de­
veloped by Hiatt et al.1 8  (r=0.89 for 
ACD and r=0.90 for VO2  max). Be­
sides, they point to the high ICC value 
of the proposed test representing 0.96 
for ICD, 0.98 for ACD as well as 0.97 
for VO2 max.
It is equally shown that the subse­
quent evaluation of patients from the 
control group not subjected to treat­
ment through the application of the 
gradual test did not display a signifi­
cant increase in the walking distance 
(ICD or ACD), as was the case in the 
test with a constant load1 4 , 2 9 . Such 
a stability in measurement makes 
a clinical interpretation of the research 
easier, for actual data on the walking 
possibilities of a patient limited by 
claudication are supplied2 , 1 8 . Never­
theless, in a similar way to the appli­
cation of the test with constant load, 
also here it follows to remember about 
the necessities for an earlier, practical 
familiarization on the part of the pa­
tient with the way of walking on 
a treadmill. It is evaluated that the size 
of the test group as equally that of the 
control group with the use of the test 
with increasing load should be no less 
than 22 patients in order to maintain 
reliable results1 8 . However, the 
evaluation of progress in treatment 
expressed in the form of time increase 
or the distance walked becomes prob­
lematic as a result of the increasing 
load in the subsequent minutes of the 
test.
In conducting walking tests on a tread­
mill it follows to avoid patient hand­
rail support so as to avoid significant 
reduction in the load on the lower
limbs30 It is shown that although use 
of the rail does not influence the 
hemodynamic parameters it results in 
an inflating of the results (ICD and 
ACD) of the walking tests both with 
constant load as with an increasing 
one, and therefore it is recommended 
that the rails are used only as an ele­
ment maintaining balance if this is 
necessary for patient safety31. In prac­
tice the patient may form his hand into 
a fist and simultaneously support him­
self on the rail with a solitary finger to 
maintain balance30.
Walking test on a treadmill with 
increasing pain threshold speed 
(PTS). The test is conducted at a zero 
angle of treadmill incline. The initial 
speed is 1.5 km/h and undergoes an 
increase of 0.1 km/h every 10 metres. 
The speed at which lower limb mus­
cle pain appears is evaluated, as well 
as the maximum speed i.e. the speed 
at which a patient refuses to make an 
effort as a result of the increasing pain 
experienced. The person conducting 
the test does not motivate the patient 
to continue the effort. The authors of 
the test32 propose the simultaneous 
registering of the frequency of the 
heart rate (HR) at the end of every 10 
metre section. The test is stopped also 
when the HR reaches the value of 
80% of the maximum (in relation to 
age) HR and also for reasons different 
than vascular ones, which prevent 
walking at the desired speed. The re­
sults of the PTS test correlate well 
with the ICD values (r=0.83) of the 
treadmill test with an increasing load, 
as well as with a six-minute distance 
(r=0.72) and ABI (r=0.64). The au­
thors of the test consider that it may 
be especially used to evaluate the re­
sults of rehabilitation in a group of 
patients with intermittent claudica­
tion. The PTS test may turn out to be 
a good research tool although it re­
quires validation on a representative 
group of patients.
The ergometer cycle test. This test 
promoted by Gardner3 3  for the eva­
luation of patients with intermittent 
claudication was relatively rarely 
used in this group of patients. The 
test is conducted at a frequency of 60 
revolutions per minute, at an initial 
load of 20W maintained for 5 mi­
nutes. Subsequently the load was in­
creased by 20W every 3 minutes until 
there was a refusal to continue the 
exertion as a result of the intensifica­
tion of pain experienced. Askew et 
al.3 4  in comparing the test on the 
ergometer cycle to the gradual test on 
the treadmill, note the small amount 
of variability within a group of pa­
tients with intermittent claudication 
(CV=7%) in relation to the treadmill 
test, where CV calculated on the basis 
of three subsequent tests was 16%. 
Besides, the authors did not find dif­
ferences in the area of the maximum 
exertion values VO2  and HR between 
the compared tests and consequently 
suggested that both tests are con­
nected with a similar cardio-vascular 
and metabolic load. However, there 
was a significant difference in the 
maximum time of exertion/effort, 
which was close to 40% longer for the 
ergometer cycle. At the same time 
there was noted a strong correlation 
(r=0.85) between the maximum time 
of exertion/effort obtained on the 
ergometer cycle as well as in the 
gradual test on the treadmill.
5
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Walking tests
6-Minute Walk Test. It owes its 
usability to the fact that this is not 
a time-consuming test, one that does not 
require specialist equipment as well as 
being well liked by the patients them­
selves -  it does not arouse a sense of 
anxiety as well as aptly portraying the 
walking possibilities. It is considered 
that the exertion manifested during the 
test’s realisation is more representa­
tive for day-to-day activity in com­
parison to other forms of testing e.g. 
a treadmill test35 and that the results of 
the test (the total 6-minute walking 
distance) correlates with the results of 
the gradual test on the treadmill within 
the range of ICD (r=0.34), ACD 
(r=0.52) as well as the post-exertion 
ABI (r=0.55)36.
The tested individual has as his task 
the covering of a flat surface, a corri­
dor, for the greatest distance mana­
geable in the course of six minutes, 
walking between two poles placed ap­
proximately 30 metres from each 
other. Evaluated are ICD, ACD as 
well as the complete (six-minute) dis­
tance walked. If the patient, before the 
elapsing of the six minutes, has to stop 
as a result of pain experienced in the 
lower limbs the ACD is noted and the 
patient rests until such time that they 
are able to continue the walk. The test 
ends with the completion of the six 
minutes. During the test the patient is 
verbally encouraged to walk (every 
two minutes), as well as encouraged 
to continue the walk while resting if 
this is necessary as a result of intensi­
fied pain in the muscles of the lower 
limbs36,37. A paedometer may also be 
used during the test to evaluate the 
total amount of steps taken36. Mont­
gomery and Gardner36 , in evaluating 
the usefulness of the six-minute walk 
test in a group of patients with inter­
mittent claudication, estimate the ICC 
value to be 0.90 to 0.94 while Teixeira 
da Cunha-Filho et al.38 evaluate the 
ICC for the six-minute test as 0.81 for 
ICD, 0.63 for ACD and 0.84 for the 6- 
minute distance walked, with the CV 
at 18%, 31,8%, and 20,3% respec­
tively, which points, however, to 
a higher variability of results than 
those given by the team of Montgom­
ery, Gardner36 (CV in the range of 10­
12%) nine years previously. This test
appears, however, of little use in pa­
tients, for, with its relatively long 
walking distance, they do not obtain 
ACD before the elapsing of the six 
minutes, particularly in the evaluation 
of the effects of walking training on 
the treadmill. Such training is con­
ducted as standard for three months at 
a constant speed of 3.2 km/h, and as 
a measure of progress in treatment the 
exertion load is increased through an 
increase in the incline angle of the 
treadmill11. Therefore, after the end of 
training, the patient may not sense the 
need to walk faster which will result 
in a small improvement in the six- 
minute distance walked.
Shuttle Walk Test. This was dem­
onstrated for the first time in 1992 by 
Singh as a diagnostic instrument for 
patients with lung diseases39. During 
the test the patient covers a 10 metre 
section, there and back, marked out on 
a flat surface -  a corridor, at 
a speed established by sounds emitted 
at an appropriate rhythm. The test 
may be carried out at a constant rate 
(4 km/h) or increasing (at an initial 
speed of 3 km/h, increasing by 0.5 
km/h for every minute)38. The maxi­
mum time for the test duration is 12 
minutes. The set parameters cover 
ICD, ACD, as well as the entire dis­
tance of the walk. The variability of 
this test is in the ACD measurement: 
15.9% in the test with an increasing 
speed and 21.1% for the one with a 
constant speed39. However, Zwierska 
et al.40 evaluate ICC respectively at 
0.87 and 0.82. Different values are 
given by Teixeira da Cuhna-Filho et 
al.38 evaluating that in the test with 
increasing speed ICC is 0.72 for ICD 
as well as 0.90 for ACD, while they 
note CV at 26.8 % for ICD and 9.1% 
for ACD. The authors, in conducting 
a direct comparison with the six- 
minute test in the group of patients 
with intermittent claudication, show 
that the shuttle walk test is character­
ised by a higher ICC and the results 
obtained are characterised by a lower 
variability. The shuttle walk test is 
also an alternative for treadmill tests, 
it does not require specialist equip­
ment or qualified personnel and may 
be conducted in almost any condi­
tions. Zwierska et al.40 , in comparing 
the shuttle walk test with the treadmill 
test with constant load, show that the
shuttle walk test with increasing speed 
is characterised by the same repro­
ducibility (ICC=0.87), besides it bur­
dens the cardio-vascular system to 
a lesser degree (a lower increase in 
HR and blood pressure) and is pre­
ferred by patients.
Walking tests are widely popular­
ised methods in the testing of patients 
with intermittent claudication. They 
are, however, not a sufficiently com­
prehensive tool for the evaluation of 
this patient group; for although they 
precisely define the change in the dis­
tance walked during treatment they do 
not evaluate the influence of this 
change on the daily functioning of the 
patient within the environment around 
him. There occurs, therefore, the need 
to use a method which would describe 
the patient’s functional answer to the 
training programme employed26.
Other functional tests 
and measurements of movement 
activity
Functional tests and the monitoring of 
movement activity may play a signifi­
cant role in the characterisation of pa­
tient functional possibilities both be­
fore and after the application of treat­
ment. As gait is the fundamental 
means by which a patient changes lo­
cation, there are also added to func­
tional tests the earlier mentioned 
walking tests conducted on a flat sur­
face. Amongst the remaining patients 
with intermittent claudication the fol­
lowing found application:
Repeated Chair Rises. The patient 
is instructed to get up from a chair 
five times with arms crossed on the 
chest in the shortest time. The time 
taken for task completion is evalu­
ated. McDermott et al.41, Guralnik et 
al.42 point to the good test reprodu­
cibility (ICC=0.73).
Standing Balance. The test assesses 
the patient’s balance in three different 
positions: 1) standing with feet to­
gether, 2) standing with feet posi­
tioned parallel whereby the heel of 
one foot is positioned at the level of 
the toes of the second, 3) standing one 
foot after another in a single line. Each 
of the positions needs to be main­
tained for 10 se-conds41. The repro­
ducibility of the test (ICC) is high and 
evaluated at 0.9742
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Four-Meter Walking Velocity.
During the test the patient covers 
a four-metre section: at a comfortable 
pace as well as as fast as possible. 
During the measurement at the com­
fortable pace the patient is instructed 
to walk at his/her normal speed ‘like 
they would normally go shopping’41. 
The test is conducted twice for each 
of the speeds. The best result is used 
for the analysis.42. The test begins 
with the patient in a standing posi­
tion, with feet together, and ends 
when the whole foot has crossed the 
finishing line43. The reproducibility of 
this test is high and represents 0.83 
and 0.88 respectively for the measure­
ment of the comfortable and maxi­
mum speed walk44.
Short physical performance bat­
tery (SPPB). This is a combination of 
the above presented tests: getting up 
from a chair, balance standing as well 
as speed over a four-metre section. Each 
of these parts is given points from 0 
(when the test is impossible for realisa­
tion) to 4 points. The maximum that 
may be obtained is 12 points37,45,41. 
SPPB is an objective measure of the 
function of the lower limbs, enabling 
the detecting of a risk in limitations 
appearing with regard to the carrying 
out of everyday activities, a lack of 
independence and the need for con­
stant care42,46.
Active pedal plantar flexion (APP). 
This was proposed by Harris et al.47 
for the evaluation of patients with in­
termittent claudication. The advantage 
of this method of evaluation involves 
first and foremost its ease in practical 
realisation in all conditions. McPhail 
et al.48 in comparing the active pedal 
plantar flexion test with the test on the 
treadmill with constant load in pa­
tients with intermittent claudication 
points to a very high correlation 
(r=0.95) in the area of post exertion 
ABI. The test is conducted in a stand­
ing position. The authors propose the 
full scope of standing on one’s toes, 
fifty times with knees unbent. After 
completion, the patient returns imme­
diately to the starting position 
(without waiting). During the test, 
support with the thumbs against the 
wall with the aim of maintaining ba­
lance is permissible. Amirhamzeh et 
al.49 propose that the standing on 
one’s toes be carried out at the maxi­
mum tolerable speed rate (at least one 
act a second). The test is well liked by 
patients although its main limitation in 
evaluation are orthopaedic problems 
in the foot making the correct realisa­
tion of the test impossible.
Monitors of activeness. Daily 
physical activity may be measured by 
means of an accelerometer and pae- 
dometer, instruments estimating the 
subsequent quantity of used energy 
and the steps taken within the course 
of a whole day through a defined pe­
riod of time -  for example, several 
days, a week. The usefulness of these 
methods in the evaluation of patients 
with intermittent claudication has 
been noted by Sieminski et al.53 as 
well as McDermott et al.44,45 In using 
a Caltrac type accelerometer it has 
been claimed that intermittent claudi­
cation patient activity is over 40% 
lower than the activity of individuals 
of a similar age without claudication39. 
It is estimated that the ICC for the 
measurement of daily physical activity 
measured with an accelerator is 0.84 
while 0.86 for the measurement of 
steps by means of a paedometer. 
Sieminski et al.53 as well as Nasr et 
al.54 point to, however, a moderate 
correlation between the average daily 
number of steps measured by means 
of a paedometer and ACD evaluated 
in a treadmill test (r=0.35), post exer­
tion ABI (r=0.35), physical function­
ing (r=0.31) evaluated by the Short 
Form 36 questionnaire, as well as by 
the results of the Walking Impairment 
Questionnaire at r =0.42. It is noted 
that accelerometer and paedometer 
measurements providing objective 
data as to the physical activity of pa­
tients may serve in eliminating the in­
accuracies appearing in the question­
naire tests.26 There are proposed 
monitors enabling the simultaneous 
measurement of heart activity. Acti­
vity monitors of the Vitalog type ena­
bling a simultaneous measurement of 
physical activity and the registration 
of ECG were used by Regensteiner et 
al.26, while Coughlin et al.55 propose 
the application of a Peripheral Arterial 
Disease Holter Control Device - 
(PADHOC) in the evaluation of the 
functional possibilities of patients with 
intermittent claudication, emphasising 
that this instrument enables the 
evaluation of various aspects con­
nected with patient locomotion in the 
natural environment. At present the 
role of activity monitor may be also 
fulfilled by a Global Positioning Sys­
tem (GPS). Using GPS in the evalua­
tion of daily locomotion, which was 
proposed by Le Faucheur et al.9 
in 2008, has to this day not found 
widespread use. Nonetheless the au­
thors point to a high correlation 
(r=0.81) between the ACD measured 
in the treadmill test and the ACD re­
gistered by a GPS.
Strength testing and muscular 
endurance
Tests on the isometric strength of par­
ticular muscle groups of the lower 
limbs are the most often carried out44. 
There is research that talks of the sig­
nificant correlation occurring between 
a lowered value of flexor and extensor 
strength for the hip joint as well as the 
knee joint flexors and a lowered value 
of the ABI indicator50. Together with 
the intensification of the ischaemia of 
the lower limbs the flexor strength of 
the intertarsal joint also diminishes51. 
Cameron et al.52 proposed the use of 
an ergometer (Stresst’er ergometer) in 
the evaluation of the strength of the 
calf muscles. A patient in a lying posi­
tion bends the foot plantarally against 
a 8.2 J resistance pressing down on 
the pedal of the ergometer at a recom­
mended rhythm of 60 times a minute. 
The test was stopped after two min­
utes or as a result of an intensification 
in pain in the muscles of the tested 
limb. The number of repeats carried 
out was assessed. The authors point to 
a good correlation (r=0.69) between 
the result of this test and the ACD 
measured on the treadmill with con­
stant resistance, as well as the post­
exertion ABI (r=0.48). The device, 
despite its simplicity, has not seen 
widespread application. However, it 
seems that it could be useful in asses­
sing patients with PAD of the lower 
limbs, for whom it is not possible to 
conduct walking tests as a result of the 
additional gait disorders (unconnected 
with claudication) as equally for those 
patients who have a systematic contra­
indication for this type of exertion 
exercise. At present significantly more 
costly isokinetic chairs are used in the 
assessing of muscle stamina and
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strength, these are noted for their high 
reproducibility of measurements (ICC) 
in the range of 0.88 to 0.9644. As it is 
suggested that walking exercise leads 
to an increased activity of the muscles 
of the lower limbs1, the testing of this 
form may be utilised in the evaluation 
by physical exercise of patients with 
intermittent claudication.
QUESTIONNAIRE
These serve the evaluation of patient 
health, his/her functional possibilities 
and quality of life. Here of signifi­
cance are the patient's expectations 
directly connected with the concept of 
a satisfying quality of life. Quality of 
life is determined by many factors: 
socio-economic, domestic, interper­
sonal relations, satisfaction with work 
while the limitations experienced by 
patients as a result of their illness have 
an enormous influence on their life­
style. It is therefore suggested that 
tests into quality of life should be 
equally included within traditional 
methods of assessing the results of 
rehabilitation in patients with PAD of 
the lower limbs56. In the evaluation of 
functional possibilities as equally the 
quality of life of those suffering from 
intermittent claudication there are also 
applied questionnaires specific for this 
problem as well as questionnaires 
serving to evaluate a general assess­
ment of patient quality of life and the 
limitations resulting from the condi­
tion of health.
The Walking Impairment Ques­
tionnaire (WIQ) was devised by the 
team of Regensteiner, Hiatt18 with the 
aim of assessing the results of treat­
ment including the rehabilitation of 
patients suffering from intermittent 
claudication. It was also used to evalu­
ate the changes in the locomotive pos­
sibilities of patients following varied 
exercises, operations applying periph­
eral arterial, pharmacological therapi- 
es57,58. The questionnaire determines 
the functional state, the patient possi­
bilities and limitations with claudica­
tion during everyday activities. It is 
short and simple to use and with it the 
most specific questionnaire for the 
evaluation of the locomotive possibili­
ties for patients with PAD of the lower 
limbs59,60. Composed of four parts
assessing the subjective feelings of the 
patient in the form of degrees of pain 
intensification, experienced difficul­
ties in the area of muscle pain of the 
lower limbs and other health problems 
limiting locomotive possibilities, as 
well as with regard to difficulties con­
nected with distance, walking speed 
on a flat surface and climbing 
stairs2,3,18. The obtained results corre­
late (r=0.33) with the ACD measure­
ment in the walking test with an in­
creasing load, as equally being stable 
in the repeated testing conducted 
within the control group2,3,18. It is con­
sidered that WIQ is an accurate 
method for the evaluation of gait abili­
ties within heterogenic groups of pa­
tients, both with claudication and 
without61. McDermott et al.61 show 
that the results of the WIQ with regard 
to the walking distance correlate with 
those obtained in the six-minute test 
(r=0.55), while in relation to the speed 
of walking they correlate with the 
four-metre distance test both at a com­
fortable speed (r=0.52) as at the maxi­
mum (r=0.56). There is also pointed 
out the ACD correlation in the tread­
mill test with the WIQ results for the 
distance walked (r=0.58) and 
speed (r=0.67). McDermott et al.61 as 
well as Coyne et al.62 evaluate the 
questionnaire results for the speed of 
walking, the distance covered and 
climbing the stairs at 0.82-0.94. Diffi­
culties may arise in European condi­
tions with the imprecise American 
unit of ‘block’ being used in the ques­
tionnaire as a measure of distance 
covered by the patient. It seems that 
the adoption of 100 metres to repre­
sent 1 block, as used in the first Polish 
WIQ version, is the optimal solution59.
Peripheral Arterial Disease Physi­
cal Activity Recall (PAD-PAR) 
serves to roughly calculate the esti­
mated patient energy expenditure in 
the week preceding testing. The pa­
tient estimates the amount of time 
spent on a given daily activity (sleep, 
work, housework, rest) of various in­
tensity: very little (0.9-2 MET), little 
(2.1-3 MET), average (3.1-5 MET) 
as well as a lot (5.1-7 MET)18,59. This 
questionnaire, appearing also as Low 
Level Physical Activity Recall 
(LOPAR)63, was developed by the 
team of Regensteiner and Haskell18
based on the initial version The Seven 
Days Physical Activity Recall64’65 and 
modified to the needs of evaluating 
the low level of activity of those with 
intermittent claudication. The PAD- 
PAR questionnaire is not, however, 
a simple instrument to use, for a pre­
cise defining of the time devoted to 
various given activities in the course 
of 24 hours is a relatively difficult 
thing to do.
Besides the above mentioned ques­
tionnaires specifically for intermittent 
claudication in the 1990s there were 
also used the Edinburgh Claudiation 
Questionnaire, being an improved 
version of the WHO/Rose Question­
naire66, and the San Diego Claudica­
tion Questionnaire, enabling the clas­
sification of patients depending on the 
nature of the complaint4 5 . Relatively 
new questionnaires are The Impact o f  
PAD on Quality o f  Life Questionnaire 
(PADQOL)6 7 , Claudication Scale 
(CLAU-S)6 8 , as well as the Intermit­
tent Claudication Questionnaire 
(ICQ)6 9 , known also as the Charing 
Cross Symptom Specific Claudication 
Questionnaire (CCCQ)7 0
Short Form 36 (SF-36) is a ques­
tionnaire enabling a general evalua­
tion of quality of life. It comprises 36 
questions answered independently by 
the patient or with the help of the re­
searcher. Not only is the daily physi­
cal functioning assessed but also the 
subjective sense of state of health tak­
ing into consideration psychic, emo­
tional, social factors, pain vitality, the 
mood of the person tested3 , 1 8 , 5 7 . In this 
way the 36 questions are grouped into 
8 categories constituting the subject of 
the assessment. The results are ex­
pressed as a percentage with 100% 
constituting a lack of limitations in the 
evaluated category. Brazier et al.7 1 , in 
carrying out for the first time in 1992 
a validation of the SF-36, indicate 
a high ICC in the range of 0.74 in the 
category ‘social functioning’ to 0.93 
for the category ‘physical function­
ing’. The questionnaire, tested on va­
ried populations (individuals with dia­
betes, heart diseases and other chronic 
illnesses), is also a recommended re­
search instrument to evaluate patients 
with vascular problems1 , 7 2 . It is con­
sidered that the application of SF-36 
in individuals with intermittent claudi­
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cation supplies a comprehensive in­
sight into the degree of disability ex­
perienced by the patient and con­
nected with the illness18,56.
Nottingham Health Profile (NHP) 
is an often used, particularly in Euro­
pean testing centres, two-part ques­
tionnaire serving the evaluation of 
quality of life57. The first section con­
cerns the subjective perception of 
health problems connected with sleep, 
life energy, emotional reactions, sense 
of social isolation, functional possi­
bilities as well as pain. In the second 
section are questions assessing the 
previously defined patient problems 
on his activity in everyday life (at 
work, during free time)58. Chetter et 
al.73 evaluate that ICC for this ques­
tionnaire is from 0.8 in the category 
‘life energy’ to 0.87 for ‘physical mo­
bility’ and ‘emotional reactions’. The 
questionnaire was successfully used 
with individuals suffering from vascu­
lar diseases both arterial as venous. It 
is, however, considered to be a less 
detailed testing instrument when com­
pared to SF-3672.
From amongst the many question­
naires serving a general evaluation of 
quality of life in a group of patients 
with intermittent claudication use has 
also been made of the European Qual­
ity o f  Life Scale (EuroQol)71 and the 
McMaster Heath Index Questionnaire 
(MHIQ)74.
CONCLUSION
Intermittent claudication does not 
only limit in a measured way the pos­
sibility of movement but also makes it 
difficult for a patient to participate in 
a full and active way in his/her per­
sonal, social and professional life. In 
assessing patients with intermittent 
claudication one cannot forget about 
the basic source for obtaining infor­
mation on the patient: a reliably con­
ducted interview incorporating addi­
tional illnesses (of the cardio-vascular 
system, the respiratory system, diabe­
tes, degenerative disease of the pe­
ripheral joints, stenosis of the verte­
bral canal, discopathy), taking medi­
cines, a history of smoking and all the 
other factors that could influence not 
only the problem of claudication but 
also the health and quality of life of 
the patient. It is the compiling of in­
formation that is the basis for correct 
diagnosis and intervention, as equally 
planning, monitoring of treatment and 
later evaluation. In the authors’ view 
in the evaluation of a patient’s func­
tional possibility there should be em­
ployed a gradual treadmill test or 
a shuttle walk test with increasing 
walking speed, incorporating the 
6-minute test supplemented by a sub­
jective evaluation of the functional 
possibilities and quality of life by 
means of the WIQ and SF-36 ques­
tionnaires. This view remains in ac­
cordance with the current international 
TASC II guidelines11. For certain, an 
assessment of those with intermittent 
claudication cannot be limited merely 
to an ABI measurement and the meas­
urement of distance walked, for as 
Housley correctly pointed out75 diffe­
rent will be the expectations in rela­
tion to the walking possibilities of 
a retired patient using a car and differ­
ent again for someone working with 
a 2 km walk to work. The testing of 
patients with intermittent claudication 
should encompass a wide spectrum of 
testing methods describing both the 
degree of disease advancement from 
the medical viewpoint as equally the 
level of the patient’s daily functioning 
taking into consideration the influence 
of the disease on difficulties experi­
enced in day-to-day life, social and 
professional life.
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